Published in Nanomedicine on July 18, 2008
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog Retin Eye Res (2013) 1.06
Acidic nanoparticles are trafficked to lysosomes and restore an acidic lysosomal pH and degradative function to compromised ARPE-19 cells. PLoS One (2012) 1.05
Nanotechnology approaches for ocular drug delivery. Middle East Afr J Ophthalmol (2013) 1.00
Vector platforms for gene therapy of inherited retinopathies. Prog Retin Eye Res (2014) 0.94
Nanotechnology and nanotoxicology in retinopathy. Int J Mol Sci (2011) 0.92
A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium. Biomaterials (2013) 0.85
Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina. Invest Ophthalmol Vis Sci (2015) 0.84
Polymeric vectors for ocular gene delivery. Ther Deliv (2011) 0.84
Synthesis and characterization of glycol chitosan DNA nanoparticles for retinal gene delivery. ChemMedChem (2013) 0.80
Nanomedicine in the application of uveal melanoma. Int J Ophthalmol (2016) 0.77
Magnetic nanoparticles: a strategy to target the choroidal layer in the posterior segment of the eye. Sci Rep (2017) 0.75
Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng (2006) 3.67
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release (2001) 2.84
Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid. Invest Ophthalmol Vis Sci (1993) 1.61
Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci (2004) 1.56
DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release (1998) 1.46
Bevacizumab for neovascular ocular diseases. Ann Pharmacother (2007) 1.29
Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases. Ann N Y Acad Sci (2006) 1.22
Temperature-responsive hydroxybutyl chitosan for the culture of mesenchymal stem cells and intervertebral disk cells. Biomaterials (2005) 1.19
PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo. Bioconjug Chem (2006) 1.15
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci (2006) 1.11
Construction, gene delivery, and expression of DNA tethered nanoparticles. Mol Vis (2006) 1.10
Chitosan-g-PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions. J Gene Med (2006) 0.94
Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res (2006) 0.92
A novel PEGylation of chitosan nanoparticles for gene delivery. Biotechnol Appl Biochem (2007) 0.89
Nanoparticle tethered antioxidant response element as a biosensor for oxygen induced toxicity in retinal endothelial cells. Mol Vis (2006) 0.87
Biodegradable polyphosphoester micelles for gene delivery. J Pharm Sci (2004) 0.83
[Effect of polysorb on adhesion of a gauze dressing to the wound surface]. Klin Khir (1992) 0.79
Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 2.40
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease. Blood (2005) 2.37
Developmental basis of nanophthalmos: MFRP Is required for both prenatal ocular growth and postnatal emmetropization. Ophthalmic Genet (2008) 2.15
Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res (2005) 1.84
Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci (2002) 1.71
Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol (2002) 1.57
Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci (2004) 1.56
Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal (2012) 1.40
Designing zonal organization into tissue-engineered cartilage. Tissue Eng (2007) 1.38
Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog. Invest Ophthalmol Vis Sci (2011) 1.33
Novel anisotropic engineered cardiac tissues: studies of electrical propagation. Biochem Biophys Res Commun (2007) 1.29
An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. Hum Mol Genet (2011) 1.29
The initial fetal human retinal vasculature develops by vasculogenesis. Dev Dyn (2006) 1.28
Astrocyte-endothelial cell relationships during human retinal vascular development. Invest Ophthalmol Vis Sci (2004) 1.27
The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas. Exp Eye Res (2005) 1.21
Photocrosslinkable polysaccharides based on chondroitin sulfate. J Biomed Mater Res A (2004) 1.20
betaA3/A1-crystallin in astroglial cells regulates retinal vascular remodeling during development. Mol Cell Neurosci (2007) 1.18
Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2002) 1.15
Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proc Natl Acad Sci U S A (2013) 1.12
Construction, gene delivery, and expression of DNA tethered nanoparticles. Mol Vis (2006) 1.10
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol Vis (2006) 1.10
Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response. Proc Natl Acad Sci U S A (2005) 1.09
A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Stem Cells Transl Med (2013) 1.09
C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. Br J Ophthalmol (2011) 1.09
Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid. Exp Eye Res (2003) 1.06
Poly(β-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo. PLoS One (2012) 1.06
Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes (2005) 1.06
Vascular precursors in developing human retina. Invest Ophthalmol Vis Sci (2008) 1.05
A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection. Am J Pathol (2010) 1.05
The embryonic human choriocapillaris develops by hemo-vasculogenesis. Dev Dyn (2007) 1.04
Effects of intravitreal indocyanine green injection in rabbits. Retina (2004) 1.03
Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD). Exp Eye Res (2009) 1.03
Retinal and optic nerve head pathology in Susac's syndrome. Ophthalmology (2011) 1.02
Lama1 mutations lead to vitreoretinal blood vessel formation, persistence of fetal vasculature, and epiretinal membrane formation in mice. BMC Dev Biol (2011) 1.02
Mutation in the βA3/A1-crystallin gene impairs phagosome degradation in the retinal pigmented epithelium of the rat. J Cell Sci (2011) 1.01
VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV. PLoS One (2013) 1.01
Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration. Arch Ophthalmol (2008) 0.99
Maturation of the fetal human choriocapillaris. Invest Ophthalmol Vis Sci (2009) 0.98
Retinal vascular development and oxygen-induced retinopathy: a role for adenosine. Prog Retin Eye Res (2003) 0.98
Acanthamoeba sclerokeratitis. Graefes Arch Clin Exp Ophthalmol (2008) 0.97
Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy. Exp Eye Res (2010) 0.97
Vitamin A up-regulates the expression of thrombospondin-1 and pigment epithelium-derived factor in retinal pigment epithelial cells. Exp Eye Res (2005) 0.97
Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization. Invest Ophthalmol Vis Sci (2009) 0.96
Canine retinal angioblasts are multipotent. Exp Eye Res (2006) 0.94
VEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes (2013) 0.94
Mechanisms for sickle red blood cell retention in choroid. Curr Eye Res (2002) 0.93
Hyperoxia inhibits several critical aspects of vascular development. Dev Dyn (2007) 0.93
Calcareous degeneration of host-donor interface after descemet membrane stripping with automated endothelial keratoplasty. Cornea (2009) 0.92
Retinopathy in monkeys with spontaneous type 2 diabetes. Invest Ophthalmol Vis Sci (2004) 0.92
VEGF 165 b in the developing vasculatures of the fetal human eye. Dev Dyn (2012) 0.91